Quantification of mitochondrial morphology in neurites of dopaminergic neurons using multiple parameters

Journal of Neuroscience Methods

Volumn 262, Issue , 2016, Pages 56-65

  Wiemerslage, Lyle ^a   Lee, Daewoo ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b OHIO UNIVERSITY   (United States)

Author keywords

Drosophila; Drp1; Mitochondria; Opa1; Parkinson

Indexed keywords

DYNAMIN; DYNAMIN RELATED PROTEIN 1; NEUROTOXIN; OPTIC ATROPHY 1 PROTEIN; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; DROSOPHILA PROTEIN; DRP1 PROTEIN, DROSOPHILA; GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN; OPA1 PROTEIN, DROSOPHILA;

ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELL DEATH; CELL POPULATION; CELL STRUCTURE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DROSOPHILA; EMBRYO; IMAGE ANALYSIS; IMMUNOFLUORESCENCE TEST; LOSS OF FUNCTION MUTATION; MITOCHONDRION; NERVE CELL CULTURE; NEURITE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; ELECTRON MICROSCOPY; GENETICS; IMAGE PROCESSING; METABOLISM; NEWBORN; NONMAMMALIAN EMBRYO; PRINCIPAL COMPONENT ANALYSIS; STATISTICS; TRANSGENIC ANIMAL; ULTRASTRUCTURE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANIMALS, NEWBORN; CELLS, CULTURED; CYTOSKELETAL PROTEINS; DOPAMINERGIC NEURONS; DROSOPHILA; DROSOPHILA PROTEINS; EMBRYO, NONMAMMALIAN; GREEN FLUORESCENT PROTEINS; GTP-BINDING PROTEINS; IMAGE PROCESSING, COMPUTER-ASSISTED; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON; MITOCHONDRIA; NEURITES; PRINCIPAL COMPONENT ANALYSIS; STATISTICS AS TOPIC;

EID: 84961384239     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2016.01.008     Document Type: Article

References (33)

1. Barrientos S.A., Martinez N.W., Yoo S., Jara J.S., Zamorano S., Hetz C., et al. Axonal degeneration is mediated by the mitochondrial permeability transition pore. Neurobiol Dis 2011, 31(3):966-978.
2. Bereiter-Hahn J. Behavior of mitochondria in the living cell. Int Rev Cytol 1990, 122:1-63.
3. Berman S.B., Pineda F.J., Hardwick J.M. Mitochondrial fission and fusion dynamics: the long and short of it. Cell Death Differ 2008, 15:1147-1152.
4. Botella J.A., Bayersdorfer F., Gmeiner F., Schneuwly S. Modelling Parkinson"s disease in Drosophila. NeuroMolecular Med 2011, 11:268-280.
5. Chang D.T.W., Reynolds I.J. Mitochondrial trafficking and morphology in healthy and injured neurons. Prog Neurobiol 2006, 80:241-268.
6. Cheng A., Hou Y., Mattson M.P. Mitochondria and neuroplasticity. ASN Neuro 2010, 2(5):243-256.
7. Cicchetti F., Drouin-Ouellet J., Gross R.E. Environmental toxins and Parkinson's diseases: what have we learned from pesticide-induced animal models?. Trends Pharmacol Sci 2009, 30(9):475-483.
8. Court F.A., Coleman M.P. Mitochondria as a central sensor for axonal degenerative stimuli. Trends Neurosci 2012, 35. Article 2012.
9. Dagda R.K., Cherra S.J., Kulich S.M., Tandon A., Park D., Chu C.T. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem 2009, 284(20):13843-13855.
10. Darya K., Ganguly A., Lee D. Quantitative analysis of synaptic boutons in cultured Drosophila neurons. Brain Res 2009, 1280:1-12.
11. Dawson T.M., Ko H.S., Dawson V.L. Genetic animal models of Parkinson's disease. Neuron 2010, 66:646-661.
12. Ghosh A., Chandran K., Kalivendi S.V., Joseph J., Antholine W.E., Hillard C.J., et al. Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model. Free Radical Biol Med 2010, 49:1674-1684.
13. Jellenger K.A. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov Disord 2012, 27(1):8-30.
14. Koopman W.J.H., Visch H.-J., Smeitink J.A.M., Willems P.H.G.M. Simultaneous quantitative measurement and automated analysis of mitochondrial morphology, mass, potential, and motility in living human skin fibroblasts. Cytometry, A 2006, 69A(1):1-12.
15. Lê S., Rennes A., Josse J., Husson F. FactoMineR: an R package for multivariate analysis. J Stat Softw 2008, 25:1-18.
16. Leonard A.P., Cameron R.B., Speiser J.L., Wolf B.J., Peterson Y.K., Schnellmann R.G., et al. Quantitative analysis of mitochondrial morphology and membrane potential in living cells using high-content imaging, machine learning, and morphological binning. Biochim Biophys Acta, Mol Cell Res 2015, 1853(2):348-360.
17. Levy O.A., Malagelada C., Greene L.A. Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis 2009, 14:478-500.
18. Liang C.-L., Wang T.T., Luby-Phelps K., German D.C. Mitochondrial mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease. Exp Neurol 2007, 203:370-380.
19. Manning-Boğ A.B., Langston J.W. Model fusion: the next phase in developing animal models for Parkinson's disease. Neurotoxicity Res 2007, 11(34):219-240.
20. Martinou J.-C., Youle R.J. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 2011, 21(1):92-101.
21. Nakamura K., Nemani V.M., Azarbal F., Skibinski G., Levy J.M., Egami K., et al. Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem 2011, 286(23):20710-20726.
22. Okamoto K., Shaw J.M. Mitochondrial morphology and dynamics in yeast and multicellular eukaryotes. Annu Rev Genet 2005, 39:503-536.
23. Park S., Lee D. Selective loss of dopaminergic neurons and formation of Lewy body-like aggregations in alpha-synuclein transgenic fly neuronal cultures. Eur J Neurosci 2006, 23:2908-2914.
24. Perier C., Vila M. Mitochondrial biology and Parkinson's disease. Cold Spring Harb Perspect Med 2012, 4:a009332.
25. Przedborski S., Jackson-Lewis V., Naini A.B., Jakowec M., Petzinger G., Miller R., et al. The Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 2001, 76:1265-1274.
26. Rafelski S.M., Marshall W.F. Building the cell: design principles of cellular architecture. Nat Rev Mol Cell Biol 2008, 9:593-602.
27. Rasband W.S. ImageJ. US Natl Inst Health 1997-2006, Bethesda, Maryland, USA. http://rsb.info.nih.gov/ij/.
28. Rugarli E.I., Langer T. Mitochondrial quality control: a matter of life and death for neurons. Eur Mol Biol Organ J 2012, 31:1336-1349.
29. Saxena S., Caroni P. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 2011, 71:35-48.
30. Smith Y., Wichmann T., Factor S.A., DeLong M.R. Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa. Neuropsychopharmacology 2012, 37:213-246.
31. Surmeier D.J., Schumacker P.T. Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease. J Biol Chem 2013, 288(15):10736-10741.
32. Wang X., Su B., Liu W., He X., Gao Y., Castellani R.J., et al. DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phyenylpyridinium toxicity in neurons: implications for Parkinson's disease. Aging Cell 2011, 10:807-823.
33. + and its rescue by D2 autoreceptors in Drosophila primary culture. J Neurochem 2013, 126:529-540.